US Patent Issued to ChromaDex on Oct. 7 for "Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development" (California, Maryland, Illinois Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,908, issued on Oct. 7, was assigned to ChromaDex Inc. (Los Angeles).

"Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development" was invented by Ryan Dellinger (Azusa, Calif.), Troy Rhonemus (Mission Viejo, Calif.), Mark Morris (Irvine, Calif.), Dietrich Conze (Garrett Park, Md.) and Amy Boileau (Libertyville, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Infant formula compositions and methods for delivering at least one compound selected from nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nic...